GLP-1 Medications Infographic
US$ 24.66
compounded glp-1 medications Compounding: When Innovation May Mean Liability GLP-1 Compounds: A Cheaper Alternative
Description
Clinical trials showed average weight loss of 14.9% of total body weight over 68 weeks (about 16 months)
Due to the ability to ameliorate IR and lipotoxicity in the pathogenesis of NASH, GLP-1R is a potential therapeutic target for NASH
Evaluate caffeine intake and consider reducing it by 25-50% to account for body composition changes
This might mean extending the time at each dose level to 6-8 weeks instead of 4, allowing more time to assess both tolerability and disease activity at each level
Source data Source Data Fig
